Find the products and resources you are looking for!
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Dept. of Immunology, Hospital Clinic de Barcelona, IDIBAPS, Spain
|09:45 a.m.||Redefining bovine and porcine in vitro models of antigen presenting cells|
Centro de Investigaciones Biológicas, CIB-CSIC, Madrid, Spain
|10:15 a.m.||TH1 priming by vaccine dendritic cells depends on IL-12 production by endogenous migratory XCR1+ dendritic cells|
Institute for Virology and Immunobiology, Julius-Maximilian University of Würzburg, Germany
|10:45 a.m.||Autologous tolerogenic dendritic cells for rheumatoid arthritis: the AuToDeCRA study|
Institute of Cellular Medicine, Newcastle University, UK
|11:15 a.m.||Tumor-derived dendritic cells to slow down tumor growth|
Vrije Universiteit Brussel, VIB, Belgium
|11:45 a.m.||Coffee break|
|12:15 p.m.||Human pDCs orchestrate the attraction of cytolytic immune effector cells in melanoma DC-vaccination|
Dept. of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
|12:45 p.m.||Update on monocyte-derived dendritic cell vaccinations to treat leukemia and solid tumors|
Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Belgium
|01:15 p.m.||Personalized whole tumor antigen vaccines in ovarian cancer: using tumors for therapy|
Center of Experimental Therapeutics, Ludwig Institute for Cancer Research, Lausanne, Switzerland
|02:00 p.m.||Refreshments and networking|
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.